Bromantane is a laboratory-made oral medication developed in Russia for persistent weakness and exhaustion and for sustaining capacity under strain. Human evidence is narrow and comes mainly from diagnosed patients; studies in healthy adults are few. Harms in short courses appear uncommon and non-serious in the published series, with activation and disturbed sleep the main concerns. Longer use, older age, pregnancy and combined stimulant use remain essentially unstudied. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Systolic and diastolic blood pressure | No established target — track change from the individual baseline | Safety check for cardiovascular activation |
| Resting heart rate | 60–100 beats per minute (standard reference range) | Safety check for cardiovascular activation |
| Alanine aminotransferase | 7–56 units per litre (standard reference range) | Safety check during hepatic metabolism |
Cadence: Baseline before any course; blood pressure, heart rate and sleep records repeated at one week and four weeks, with liver testing repeated at four weeks when baseline values or symptoms warrant it